TABLE 1.

ENABLE’s research coordination and capacity building objectives.

ENABLE’s research coordination objectives
1. Benchmark, assess and raise awareness on current practices on tackling non-adherence in different healthcare settings across Europe
This entails the exchange of best practices, facilitators/barriers, experiences and expertise of different healthcare providers (GPs, specialists, pharmacists, nurses, health psychologists) and patients in dealing with non-adherence issues in daily life and practice
2. Accelerate the availability and implementation of adherence enhancing technologies across Europe
This entails the exchange (e.g., through webplatforms, vlogs, social media) of multidisciplinary knowledge and creates awareness among healthcare providers on the availability and potential of innovative adherence measurement methods and adherence enhancing technology (electronic monitoring, eHealth apps and tools) for clinical practice
3. Gather expert input for future market applications and implementation of cutting-edge adherence enhancing technology
To support timely patient access to technology, we facilitate knowledge exchange on cost-effectiveness, market access pathways, pricing, reimbursement and permanent integration of innovative adherence interventions in different European healthcare systems and clinical guidelines
ENABLE’s capacity-building objectives
1. Bringing together currently isolated stakeholders and building up a network
To achieve breakthroughs in the development of new process to advance the implementation of adherence enhancing technologies. This will be achieved by hosting meetings, workshops and conferences. Target stakeholders include clinicians, technologists, payers, and policy makers
2. Developing a platform and trans-national practice and policy community to exchange and foster knowledge
To achieve this, a web platform will be compiled and hosted which will include a repository of best practices and technologies that can enhance medication adherence, examples of successful implementation and patient access pathways. Per intervention, an independent assessment of its effectiveness, safety and cost-effectiveness will be provided by a panel of multidisciplinary experts not having a conflict of interest. Industry (e.g., pharmaceutical, IT) may propose an intervention to be included on the platform but cannot provide the aforementioned assessment
3. Translate and disseminate knowledge on technologies to specific target groups such as early stage researchers (being within 9 years of obtaining a PhD) and researchers from countries with less research capacity, as defined by the COST association
This will be achieved by hosting meetings and workshops, organizing Training Schools and opportunities for Short-Term Scientific Missions (STSMs). Through these STSMs, early stage researchers can learn from senior investigators and policy makers on the use and regulations of technology in other countries